Q3 FY23 Earnings Presentation
Cardiovascular
7% growth driven by strong performance in CRM, TAVR, & Diagnostics
Cardiac Rhythm & Heart Failure (CRHF)
•
•
•
Cardiac Pacing Therapies: HSD growth; mid-teens WW Micra™ growth driven by China
Micra TM AV launch and increased market penetration
Defibrillation Solutions: HSD growth driven by strong implant rates and ICD
replacement headwinds subsiding; Aurora EV-ICDTM1 CE Mark received last week
Procedure Innovations: Low-20s growth on strength of TYRXTM antibacterial envelopes
CAS: HSD WW ex. China growth driven by continued adoption of Arctic Front™
cryoablation catheters, offset by competitive pressure in Europe and China VBP;
PulseSelect™ PFA catheter¹ PULSED AF pivotal trial results to be presented as a LBCT
at ACC.23 on March 6th
Diagnostics: LINQ IITM global launch expansion accelerates with unrestricted supply
Structural Heart & Aortic (SHA)
Structural Heart: LDD WW & U.S. TAVR growth driven by EvolutTM FX launch and SVD
Durability Data showing CoreValve TM and Evolut™ as first and only TAVR platforms to
outperform SAVR at 5 years
Aortic: DD growth on supply improvements for both AAA & TAA; continued pressure
from Valiant Navion TM recall
Coronary and Peripheral Vascular (CPV)
Coronary: Y/Y & sequential DES share gains driven by Onyx Frontier™ launch; U.S. &
WE PCI procedures below pre-COVID levels
Peripheral Vascular Health: Growth in DCBs, Vascular Embolization, and Superficial
Venous offset by weakness in Directional Atherectomy, Peripheral Stents and PTA
balloons
10 Q3 FY23 Earnings Presentation | February 21, 2023
Micra TM AV and
VR Transcatheter
Pacing System
Medtronic
Micra AV
Arctic Front™
cryoablation
catheters
LINQ II™M
Insertable
Cardiac Monitor
Evolut™ FX
TAVR System
21%
CPV | $581M
-3.6% Y/Y Rep
+1.5% Y/Y Org
$2,772M
+1.0% Y/Y Rep
+6.5% Y/Y Org
27%
SHA $760M
+2.7% Y/Y Rep
+8.8% Y/Y Org
......52%
CRHF $1,431M
+2.1% Y/Y Rep
+7.5% Y/Y Org
Operating Unit Growth
Cardiac Rhythm Management
HSD
Cardiac Ablation Solutions
LSD
Cardiovascular Diagnostics
LDD
Structural Heart & Aortic
HSD
Cardiac Surgery
MSD
Coronary
LSD
Peripheral Vascular Health
LSD
Onyx Frontier™
DES
1) Aurora EV-ICDTM and Pulse SelectTM are not available in the U.S.
MedtronicView entire presentation